Cabergoline and aortic valve incompetence 
Cabergoline and aortic valve incompetence Patient Reports March 21, 2010
Cabergoline Side Effects Report #4669288-6
Cabergoline side effect was reported by a Physician from on May 08, 2005. Female patient, 72 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, restless legs syndrome. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5073518-9
Cabergoline side effect was reported by a Physician from GERMANY on July 21, 2006. Male patient, 70 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis. Cabergoline dosage: 1 MG (DAILY),ORAL 7 YEARS AGO. Patient recovered.
Cabergoline Side Effects Report #5087115-2
Cabergoline side effect was reported by a Physician from GERMANY on Aug 10, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, biliary cirrhosis primary. Cabergoline dosage: 1 MG (DAILY) ORAL. During the same period patient was treated with URSOFALK. Patient recovered.
Cabergoline Side Effects Report #5120033-X
Cabergoline side effect was reported by a Physician from GERMANY on Sept 18, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis. Cabergoline dosage: 1 MG (1 D), ORAL. During the same period patient was treated with URSO FALK, ACETYLSALICYLIC ACID SRT. Patient recovered.
Cabergoline Side Effects Report #4690035-6
Cabergoline side effect was reported by a Physician from on May 31, 2005. Female patient, 65 years of age, weighting 149.9 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, coronary artery disease
, hyperlipidaemia, hypertension, restless legs syndrome. Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ISOMONIT, LOVASTATIN, CARVEDIOLOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4699662-3
Cabergoline side effect was reported by a Physician from on June 14, 2005. Female patient, 65 years of age, weighting 149.9 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve calcification, aortic valve incompetence, aortic valve sclerosis, coronary artery surgery, hypertension. Cabergoline dosage: 2 MG (2 MG, DAILY) ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ISOMONIT, LOVASTATIN, CARVEDILOL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5385694-9
Cabergoline side effect was reported by a Physician from GERMANY on July 02, 2007. Female patient, weighting 174.2 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis. Cabergoline dosage: DAILY DOSE:1MG. Patient recovered.
Cabergoline Side Effects Report #4656532-4
Cabergoline side effect was reported by a Physician from on Apr 22, 2005. Female patient, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, endocarditis
, hyperkinetic heart syndrome, mitral valve incompetence. Cabergoline dosage: 4 MG , ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #4680723-X
Cabergoline side effect was reported by a Physician from on May 19, 2005. Female patient, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea exertional, endocarditis
, fatigue, hyperkinesia, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with RESTEX, MADOPAR. Patient recovered.Cabergoline Side Effects Report #4600648-5
Cabergoline side effect was reported by a Health Professional from on Feb 21, 2005. Female patient, 39 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with MADOPAR. Patient recovered.
Cabergoline Side Effects Report #5502491-1
Cabergoline side effect was reported by a Physician from GERMANY on Oct 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, left ventricular dysfunction, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence. Cabergoline dosage: DAILY DOSE:10MG. Patient recovered.
Cabergoline Side Effects Report #5127987-6
Cabergoline side effect was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 82 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure diastolic decreased, cardiac murmur, cardiomegaly, mitral valve disease, mitral valve incompetence, oedema peripheral, pulmonary congestion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4966139-7
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis, dilatation atrial, left ventricular failure, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with AMANTADINE, NACOM. Patient recovered.Cabergoline Side Effects Report #4696141-4
Cabergoline side effect was reported by a Health Professional from on June 09, 2005. Female patient, 80 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure increased, body temperature decreased, cardiac failure congestive, echocardiogram abnormal, hyperphagia, mitral valve disease, mitral valve incompetence. Cabergoline dosage: 1 MG (1 MG, QD), ORAL. During the same period patient was treated with MADOPAR, SYMMETREL, MICARDIS, SELBEX, AMLODIPINE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5094391-9
Cabergoline side effect was reported by a Physician from GERMANY on Aug 16, 2006. Female patient, 75 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, hypertensive heart disease, mitral valve incompetence. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR, BISOPROLOL, HYDROCHLOROTHIAZIDE. Patient recovered.Cabergoline Side Effects Report #5608635-5
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Jan 20, 2008. Female patient, 75 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac arrest , cardiogenic shock, chest pain , dyspnoea, hypotension, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: DAILY DOSE:4MG. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #5653886-7
Cabergoline side effect was reported by a Physician from JAPAN on Feb 28, 2008. Male patient, 75 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure. Cabergoline dosage: unknown. During the same period patient was treated with GLYSENNID, SELEGILINE HYDROCHLORIDE, ACENALIN, FAMOTIDINE, SYMMETREL, ZONISAMIDE, MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4920786-7
Cabergoline side effect was reported by a Physician from JAPAN on Feb 03, 2006. Female patient, 73 years of age, weighting 84.44 lb, was diagnosed with parkinson's disease
, reflux oesophagitis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve stenosis, blood urea increased, cardiac failure chronic, cerebral infarction, condition aggravated, face oedema, pleural effusion, reflux oesophagitis. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, EC DOPARL, SYMMETREL, ASPIRIN, ZOLPIDEM TARTRATE, LASIX, ALDACTONE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4996295-6
Cabergoline side effect was reported by a Physician from SPAIN on Apr 27, 2006. Male patient, 73 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic elongation, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation , cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5414313-8
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea, oedema peripheral, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with DOPASTON, TOLEDOMIN, THYRADIN S. Patient recovered.Cabergoline Side Effects Report #4645346-7
Cabergoline side effect was reported by a Physician from on Apr 11, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, aortic valve incompetence, blood pressure systolic increased, cardiac failure, cardiomegaly, dilatation atrial, dyspnoea exertional, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 2 MG , ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4658886-1
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure systolic increased, cardiac failure, mitral valve prolapse, oedema peripheral, pleural effusion, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4781130-1
Cabergoline side effect was reported by a Physician from SPAIN on Sept 14, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac failure. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4874914-2
Cabergoline side effect was reported by a Physician from SPAIN on Dec 28, 2005. Male patient, 72 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic disorder, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation , cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4870603-9
Cabergoline side effect was reported by a Physician from GERMANY on Dec 19, 2005. Male patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, left ventricular failure, mitral valve incompetence, pleural effusion, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with LEVODOPA, AMANTADINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4931079-6
Cabergoline side effect was reported by a Physician from GERMANY on Feb 13, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.Cabergoline Side Effects Report #4960888-2
Cabergoline side effect was reported by a Physician from GERMANY on Mar 14, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic dilatation, aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.Cabergoline Side Effects Report #4659075-7
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Female patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4659129-5
Cabergoline side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: (3 MG), ORAL. During the same period patient was treated with SINEMET, ATORVASTATIN CALCIUM, LEVOTHYROXINE, LAMOTRIGINE, ZOPICLONE. Patient recovered.Cabergoline Side Effects Report #4699650-7
Cabergoline side effect was reported by a Physician from on June 14, 2005. Female patient, 70 years of age, weighting 136.7 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, aortic valve disease mixed, aortic valve incompetence, cardiac failure. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with MANIDON, ADIRO, SINEMET, SEROXAT NOVO NORDISK. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4629438-4
Cabergoline side effect was reported by a Physician from on Mar 24, 2005. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aortic valve incompetence, cardiac failure, cardiac valve disease, cardiomegaly, condition aggravated, echocardiogram abnormal, mitral valve incompetence, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4917899-2
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Feb 06, 2006. Female patient, 69 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac murmur, mitral valve incompetence, nightmare, pulmonary hypertension , tricuspid valve incompetence, visual disturbance. Cabergoline dosage: 4 MG (1 D), ORAL. During the same period patient was treated with ZOLOFT, MADOPARK, TOLTERODINE TARTRATE. Patient recovered.Cabergoline Side Effects Report #4596675-7
Cabergoline side effect was reported by a Physician from on Feb 14, 2005. Female patient, 68 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: amaurosis fugax, aortic injury, aortic valve incompetence, cardiac failure, condition aggravated, left ventricular failure, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, QD), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE, FUROSEMIDE, AMILORIDE W, LEVODOPA W, CLOPIDOGREL BISULPHATE, CITALOPRAM, PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4742129-4
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on July 25, 2005. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, fibrosis, mitral valve disease, mitral valve incompetence. Cabergoline dosage: 6 MG (EVERY DAY), ORAL. During the same period patient was treated with GLUCOSAMINE, AMANTADINE. Patient recovered.Cabergoline Side Effects Report #5176562-6
Cabergoline side effect was reported by a Physician from JAPAN on Nov 24, 2006. Female patient, 67 years of age, weighting 84.66 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aortic valve incompetence, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chest discomfort, leukaemia, malaise, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4 MG (1 D), ORAL. During the same period patient was treated with LUVOX, JUVELA NICOTINATE, CEROCRAL, RIZE, KOLANTYL, ULCERMIN, GRAMALIL, HYDREA. Patient was hospitalized. Patient died on 10/22/2006.Cabergoline Side Effects Report #4753569-1
Cabergoline side effect was reported by a Physician from GERMANY on Aug 15, 2005. Female patient, 67 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, atrial flutter, dyspnoea, dyspnoea at rest, dyspnoea exertional, inflammation, pericarditis constrictive, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, COMTESS, AMANTADINE, NACOM, EDRONAX. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4774593-9
Cabergoline side effect was reported by a Physician from JAPAN on Sept 08, 2005. Female patient, 67 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, SELEGILINE HYDROCHLORIDE. Patient recovered.Cabergoline Side Effects Report #4577451-8
Cabergoline side effect was reported by a Physician from on Jan 26, 2005. Male patient, 66 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dizziness , dyspnoea, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG (2 MG, ) , ORAL. During the same period patient was treated with MADOPAR, ENTACAPNE. Patient recovered.Cabergoline Side Effects Report #4779043-4
Cabergoline side effect was reported by a Physician from SWEDEN on Sept 12, 2005. Male patient, 66 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, atrial fibrillation , blood pressure increased, cardiac murmur, erectile dysfunction , eye disorder, hallucination, visual, mitral valve incompetence, myocardial infarction. Cabergoline dosage: 0.5 MG (DAILY); ORAL. During the same period patient was treated with TOLTERODINE TARTRATE, ASPIRIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4757117-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Aug 17, 2005. Female patient, 65 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea. Cabergoline dosage: (5 MG), ORAL. During the same period patient was treated with SINEMET, AMANTADINE, NAPROXEN. Patient recovered.Cabergoline Side Effects Report #4686425-8
Cabergoline side effect was reported by a Health Professional from on May 25, 2005. Female patient, 64 years of age, weighting 116.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary oedema. Cabergoline dosage: (6 MG), ORAL. During the same period patient was treated with FUROSEMIDE, RAMIPRIL. Patient recovered.Cabergoline Side Effects Report #4933991-0
Cabergoline side effect was reported by a Physician from GERMANY on Feb 21, 2006. Female patient, 64 years of age, weighting 160.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, hypertension, mitral valve incompetence, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 8 MG (4 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMANTADINE, LEVOTHYROXINE, PRESOMEN COMPOSITUM, LISINOPRIL, DIOVAN HCT, BISOPROLOL, NITRENDIPINE, SIMVASTATIN. Patient recovered.Cabergoline Side Effects Report #5150896-3
Cabergoline side effect was reported by a Physician from JAPAN on Oct 26, 2006. Female patient, 63 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve calcification, aortic valve incompetence, blood pressure increased, cardiac murmur, cardiac valve disease, electrocardiogram st segment abnormal, mitral valve disease, tricuspid valve disease. Cabergoline dosage: 4 MG (1 D),ORAL. Patient recovered.Cabergoline Side Effects Report #4896417-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Jan 17, 2006. Female patient, 62 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, EVERY DAY), ORAL. During the same period patient was treated with FUROSEMIDE, PERINDOPRIL, SPIRONOLACTONE, SALMETEROL, SALBUTAMOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4659578-5
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Male patient, 61 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 9 MG , ORAL. During the same period patient was treated with MADOPAR, SINEMET. Patient recovered.Cabergoline Side Effects Report #4680702-2
Cabergoline side effect was reported by a Physician from on May 20, 2005. Female patient, 61 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, chest discomfort, palpitations, pulmonary arterial pressure increased, tricuspid valve incompetence. Cabergoline dosage: 4 MG (2 MG, EVERY DAY), ORAL. During the same period patient was treated with MADOPARK, PROPRANOLOL, ELDEPRYL. Patient recovered.Cabergoline Side Effects Report #4710055-2
Cabergoline side effect was reported by a Physician from ITALY on June 23, 2005. Female patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with MANTADAN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4849483-3
Cabergoline side effect was reported by a Physician from FINLAND on Nov 28, 2005. Female patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac murmur, ventricular dysfunction. Cabergoline dosage: unknown. During the same period patient was treated with ELDEPRYL, ATARIN, TIZANIDINE. Patient recovered.Cabergoline Side Effects Report #4878009-3
Cabergoline side effect was reported by a Physician from FINLAND on Jan 02, 2006. Female patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac murmur, ventricular dysfunction. Cabergoline dosage: unknown. During the same period patient was treated with ELDEPRYL, ATARIN, TIZANIDINE. Patient recovered.Cabergoline Side Effects Report #4886854-3
Cabergoline side effect was reported by a Physician from GERMANY on Jan 09, 2006. Male patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, arteriosclerosis, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, PARKINSAN, UROXATRAL. Patient recovered.Cabergoline Side Effects Report #4932515-1
Cabergoline side effect was reported by a Physician from GERMANY on Feb 21, 2006. Male patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, carotid artery atheroma, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, PARKINSAN, UROXATRAL. Patient recovered.Cabergoline Side Effects Report #5086014-X
Cabergoline side effect was reported by a Pharmacist from SPAIN on Aug 07, 2006. Female patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: 4 MG (1 MG), ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA, BENSERAZIDE, CARBIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4765597-0
Cabergoline side effect was reported by a Physician from SPAIN on Aug 24, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary hypertension . Cabergoline dosage: 6 MG (DAILY INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with SINEMET, STALEVO, BESITRAN. Patient recovered.Cabergoline Side Effects Report #4850529-7
Cabergoline side effect was reported by a Physician from SPAIN on Nov 30, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood lactate dehydrogenase increased, cardiomegaly, haemoptysis, mitral valve incompetence, nasopharyngitis, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with AMANTADINE, DILUTOL, MOTILIUM, SINEMET, STALEVO, BESITRAN. Patient recovered.Cabergoline Side Effects Report #5524322-6
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Nov 12, 2007. Female patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, SINEMET CR, ZELAPAR. Patient recovered.Cabergoline Side Effects Report #5657296-8
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Feb 27, 2008. Female patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, condition aggravated, heart valve incompetence, left atrial dilatation, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with REQUIP, SINEMET, SINEMET CR, ZELAPAR. Patient recovered.Cabergoline Side Effects Report #4965978-6
Cabergoline side effect was reported by a Health Professional from NORWAY on Mar 24, 2006. Male patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiomyopathy , mitral valve incompetence. Cabergoline dosage: 6 MG (6 MG, 1 IN 1 D), ORAL. During the same period patient was treated with STALEVO. Patient recovered.Cabergoline Side Effects Report #4659579-7
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Female patient, 52 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (DAILY), ORAL. Patient recovered.Cabergoline Side Effects Report #4659081-2
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 51 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 12 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4664720-6
Cabergoline side effect was reported by a Physician from on May 06, 2005. Male patient, 51 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 12 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4659581-5
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Female patient, 47 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: 6 MG (2 MG DAILY) ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #5144554-9
Cabergoline side effect was reported by a Physician from GERMANY on Oct 18, 2006. Male patient, 45 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: 6 MG, ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5165034-0
Cabergoline side effect was reported by a Physician from GERMANY on Nov 14, 2006. Male patient, 45 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, pulmonary hypertension , tricuspid valve incompetence, ventricular hypertrophy. Cabergoline dosage: 6 MG (1 D); ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE, MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4674025-5
Cabergoline side effect was reported by a Health Professional from on May 12, 2005. Female patient, 44 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary hypertension . Cabergoline dosage: 4 M G (4 MG, DAILY INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with SINEMET CR. Patient recovered.Cabergoline Side Effects Report #5133242-0
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve incompetence, aortic valve sclerosis, dilatation ventricular, mitral valve incompetence, mitral valve prolapse, mitral valve sclerosis, oedema peripheral, treatment noncompliance. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5446575-5
Cabergoline side effect was reported by a Physician from JAPAN on Aug 28, 2007. Male patient, weighting 149.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: DAILY DOSE:2MG. During the same period patient was treated with PERMAX, AKINETON, ZANTAC, EC DOPARL, SYMMETREL. Patient recovered.Cabergoline Side Effects Report #5478685-0
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on Sept 25, 2007. Female patient, weighting 90.39 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic stenosis, aortic valve incompetence, cardiac failure congestive, heart valve calcification, mitral valve incompetence. Cabergoline dosage: DAILY DOSE:4MG. During the same period patient was treated with PERMAX, PERGOLIDE MESYLATE, MADOPAR, ARTANE, ADALAT, RYTHMODAN, LASIX, GASMOTIN. Patient recovered.Cabergoline Side Effects Report #6025156-9
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Dec 16, 2008. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alopecia, aortic valve incompetence, arrhythmia , delusion, dyspnoea, fatigue, hypertension, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4MG PER DAY. During the same period patient was treated with NACOM. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4575789-1
Cabergoline side effect was reported by a Physician from on Jan 24, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure increased, dyspnoea, dyspnoea exertional, face oedema, histology abnormal, mitral valve disease, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR, ACETYLSALICYLIC ACID SRT, ZUMESTON. Patient recovered.Cabergoline Side Effects Report #4659586-4
Cabergoline side effect was reported by a Physician from on Apr 29, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence. Cabergoline dosage: 6 MG, ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4710538-5
Cabergoline side effect was reported by a Physician from GERMANY on June 27, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac output decreased, coronary artery atherosclerosis, dyspnoea, mitral valve disease, mitral valve incompetence, mitral valve sclerosis, pleural effusion. Cabergoline dosage: DAILY, ORAL ; 6 MG (DAILY) ORAL. During the same period patient was treated with SELEGILINE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4765276-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 26, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, coronary artery disease , mitral valve incompetence, mitral valve sclerosis, pleural effusion, pneumonia , pulmonary congestion, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4774991-3
Cabergoline side effect was reported by a Physician from GERMANY on Sept 08, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis, anaemia, aortic valve incompetence, arterial fibrosis, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchial obstruction. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4785374-4
Cabergoline side effect was reported by a Physician from GERMANY on Sept 20, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis, anaemia, aortic valve incompetence, arterial fibrosis, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchial obstruction. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5499981-7
Cabergoline side effect was reported by a Consumer or non-health professional from FRANCE on Oct 15, 2007. Female patient, 53 years of age, was diagnosed with galactorrhoea, breast pain and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5133143-8
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Oct 04, 2006. Female patient, 57 years of age, weighting 176.4 lb, was diagnosed with dementia
, cardiac failure and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, atrial fibrillation . Cabergoline dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BUMETANIDE, RIVASTIGMINE TARTRATE, ZOFRAN. Patient recovered.Cabergoline Side Effects Report #5218471-X
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, arrhythmia
, cardiac valve disease, chest pain , dyspnoea, mitral valve incompetence, oedema, syncope, tricuspid valve incompetence. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5298356-3
Cabergoline side effect was reported by a Physician from ITALY on Mar 27, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5119969-5
Cabergoline side effect was reported by a Physician from GERMANY on Sept 19, 2006. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, condition aggravated. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5503415-3
Cabergoline side effect was reported by a Health Professional from SWEDEN on Oct 22, 2007. Male patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence. Cabergoline dosage: DAILY DOSE:2MG-TEXT:DAILY TDD:2 MG. During the same period patient was treated with MADOPARK, STALEVO, CARBIDOPA AND LEVODOPA, FOLACIN, BEHEPAN, SINEMET MITE. Patient recovered.